Clinical Trial Update: Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ascorbic acid with chemotherapy for relapsed/refractory lymphoma, clonal cytopenia of undetermined significance (CCUS), and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Undetermined Significance
• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma with Myc and Bcl2 and or Bcl6 Rearrangements
• Hodgkin Lymphoma
• Myelomonocytic Leukemia

Drugs mentioned

• Ascorbic acid (Vitamin C)
• Chemotherapy (unspecified regimen)

Snippet

Sponsor: Mayo Clinic | Conditions: Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Status: RECRUITING